12:00 AM
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Deals

Harvard Scientific Corp, Biosphere Technologies Inc deal

HVSF acquired exclusive rights to Prostaglandin E-1 Lyophilized Liposomes to treat psoriasis...

Read the full 39 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >